When it comes to the microarray market, much of the emphasis is often on density, like the upcoming 1-million SNP whole-genome genotyping chips touted by Illumina and Affymetrix, or on emerging applications like the miRNA arrays marketed by Exiqon, Invitrogen, and CombiMatrix.
 
One frequently overlooked component of the marketplace, however, is the open-platform microarray scanner, and imaging company Vidar Systems hopes to capitalize on this by selling a newly developed system.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.